Friday, 06 Dec 2019

You are here

Stress and the Risk of Incident Inflammatory Arthritis

A prospective analysis of newly diagnosed, inflammatory arthritis (IA) patients suggests that perceived distress (stress) increases the odds of incident IA.

Data was drawn from the Studies of the Etiologies of Rheumatoid Arthritis (SERA) dataset that include people without IA who were recruited if they were a first degree relative of a RA proband or screened positive for anti‐cyclic citrullinated peptide autoantibody (ACPA). IA was defined as having at least 1 joint consistent with rheumatoid arthritis (RA)‐like synovitis based on exam. Perceived stress was assessed using the Perceived Stress Scale‐14 (PSS) in which scores can range from 0 to 56 and a higher score indicates greater perceived stress. 

In this cohort the mean total PSS score was 20.4.

A one‐point increase in the perceived distress score was significantly associated with a 10 percent increase in the risk of IA (adjusted HR: 1.10; 95%CI: 1.02, 1.19).

Total PSS and self‐efficacy were not associated with IA risk (adjusted HR: 1.05 (95%CI: 0.99, 1.10) and 1.04 (95%CI: 0.91, 1.18), respectively.

More studies are needed to confirm whether stress (a modifiable risk factor?) is associated with an increased risk of inflammatory arthritis.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Smoking Cessation Lowers RA Disease Activity and CV Risks

A multinational cross-sectional cohort study suggests that smoking cessation in rheumatoid arthritis (RA) patients is associated with lower disease activity measures, improved lipid profiles and lower rates of cardiovascular (CV) events.

Apremilast Reduces Oral Ulcers in Behcet's Syndrome

A multinational trial finds a statistically significant number of patients with Behçet's syndrome showed a greater reduction in the number of oral ulcers with apremilast compared with placebo.

Systemic JIA-Associated Lung Disease

A disease you’ve never heard of is becoming increasingly common and carries a very poor prognosis. 

For me, one of most important aspects of attending the ACR Annual Meeting is to learn about conditions that I don’t know and that may afflict my patients when I return back home. This year’s meeting was no different.

Tapering Of Therapy In RA: Maybe Not So Aggressive Next Time

This ACR has seen some more great work on tapering of therapy in rheumatoid arthritis. It’s a hot topic and one which I get asked about all the time by my patients. Commonly when I start oral csDMARDs patients want to know how long they be will on therapy and that naturally leads to a discussion about what the plan will be in the future about tapering.

ACR 2019 - Report From Day 3 (Tuesday)

Here's my summary of key studies presented Tuesday. 

Tofacitinib in Polyarticular JIA